Literature DB >> 22790246

CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome.

M J D Post1, M M Thurnher, D B Clifford, A Nath, R G Gonzalez, R K Gupta, K K Post.   

Abstract

SUMMARY: While uncommon, CNS-IRIS developing after the initiation of HAART in the setting of HIV-related severe immunosuppression is characterized by an intense inflammatory reaction to dead or latent organisms or to self-antigens due to a heightened but dysregulated immune response. While this reaction can range from mild to fulminating, encompassing a very wide clinical spectrum, it is important to recognize because changes in medical management may be necessary to prevent neurologic decline and even death. Once contained, however, this inflammatory response can be associated with improved patient outcome as immune function is restored. Among the infectious organisms that are most commonly associated with CNS-IRIS are the JC virus and Cryptococcus organisms, which will be the subject of this review. CD8 cell infiltration in the leptomeninges, perivascular spaces, blood vessels, and even parenchyma seems to be the pathologic hallmark of CNS-IRIS. While recognition of CNS-IRIS may be difficult, the onset of new or progressive clinical symptoms, despite medical therapy and despite improved laboratory data, and the appearance on neuroimaging studies of contrast enhancement, interstitial edema, mass effect, and restricted diffusion in infections not typically characterized by these findings in the untreated HIV-infected patient should raise the strong suspicion for CNS-IRIS. While CNS-IRIS is a diagnosis of exclusion, the neuroradiologist can play a critical role in alerting the clinician to the possibility of this syndrome.

Entities:  

Mesh:

Year:  2012        PMID: 22790246      PMCID: PMC8051492          DOI: 10.3174/ajnr.A3183

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  94 in total

1.  Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

Authors:  Juan Berenguer; Pilar Miralles; Julio Arrizabalaga; Esteban Ribera; Fernando Dronda; Josu Baraia-Etxaburu; Pere Domingo; Manuel Márquez; Francisco J Rodriguez-Arrondo; Fernando Laguna; Rafael Rubio; José Lacruz Rodrigo; J Mallolas; Verónica de Miguel
Journal:  Clin Infect Dis       Date:  2003-04-02       Impact factor: 9.079

2.  Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience.

Authors:  C Buckle; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

Review 3.  Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome.

Authors:  David J Riedel; Carlos A Pardo; Justin McArthur; Avindra Nath
Journal:  Nat Clin Pract Neurol       Date:  2006-10

4.  Guillain--Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection.

Authors:  E C Y Teo; A Azwra; R L Jones; Brian G L Gazzard; Mark Nelson
Journal:  J HIV Ther       Date:  2007-09

Review 5.  Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.

Authors:  J A DeSimone; R J Pomerantz; T J Babinchak
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

6.  Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.

Authors:  Sarah Gheuens; Evelyn Bord; Santosh Kesari; David M Simpson; Rajesh T Gandhi; David B Clifford; Joseph R Berger; Long Ngo; Igor J Koralnik
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

7.  Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy.

Authors:  Jaime Robertson; Matthew Meier; Jennifer Wall; Jun Ying; Carl J Fichtenbaum
Journal:  Clin Infect Dis       Date:  2006-04-28       Impact factor: 9.079

8.  Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.

Authors:  Christoph Wyen; Christian Hoffmann; Norbert Schmeisser; Andrej Wöhrmann; Nazifa Qurishi; Jürgen Rockstroh; Stefan Esser; Ansgar Rieke; Birgit Ross; Thore Lorenzen; Karina Schmitz; Werner Stenzel; Bernd Salzberger; Gerd Fätkenheuer
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10-01       Impact factor: 3.731

Review 9.  "Thinking without thinking" about natalizumab and PML.

Authors:  Richard M Ransohoff
Journal:  J Neurol Sci       Date:  2007-05-22       Impact factor: 3.181

Review 10.  HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal.

Authors:  Martyn A French
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

View more
  21 in total

Review 1.  Punctate and curvilinear gadolinium enhancing lesions in the brain: a practical approach.

Authors:  Guillaume Taieb; Alberto Duran-Peña; Nicolas Menjot de Chamfleur; Antoine Moulignier; Eric Thouvenot; Thibaut Allou; Arnaud Lacour; Khe Hoang-Xuan; Jean Pelletier; Pierre Labauge
Journal:  Neuroradiology       Date:  2015-12-23       Impact factor: 2.804

Review 2.  Neuroimaging in Central Nervous System Infections.

Authors:  Nathaniel C Swinburne; Anmol G Bansal; Amit Aggarwal; Amish H Doshi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-06       Impact factor: 5.081

3.  Reversible severe encephalitis and word deafness following rapid immune reconstitution in AIDS: a case report.

Authors:  David Roh; Melanie D Glenn; Carol K Petito; M Judith Donovan Post; Ashok Verma
Journal:  J Neurovirol       Date:  2013-04-12       Impact factor: 2.643

4.  Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries.

Authors: 
Journal:  AIDS       Date:  2014-10-23       Impact factor: 4.177

5.  When smear and molecular diagnostics fail: identification of tuberculosis in advanced HIV infection using the newly developed urine lipoarabinomannan lateral-flow assay.

Authors:  Ashar Vijay Dhana; Pauline Howell; David Spencer
Journal:  BMJ Case Rep       Date:  2014-03-10

Review 6.  Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects.

Authors:  Christie M Lincoln; Peter Fata; Susan Sotardi; Michael Pohlen; Tomas Uribe; Jacqueline A Bello
Journal:  Br J Radiol       Date:  2017-11-03       Impact factor: 3.039

Review 7.  Neurological immune reconstitution inflammatory response: riding the tide of immune recovery.

Authors:  David B Clifford
Journal:  Curr Opin Neurol       Date:  2015-06       Impact factor: 5.710

Review 8.  Update and New Directions in Therapeutics for Neurological Complications of HIV Infections.

Authors:  Ronald Ellis; Scott L Letendre
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 9.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

Review 10.  MRI imaging features of HIV-related central nervous system diseases: diagnosis by pattern recognition in daily practice.

Authors:  Mio Sakai; Masahiro Higashi; Takuya Fujiwara; Tomoko Uehira; Takuma Shirasaka; Katsuyuki Nakanishi; Nobuo Kashiwagi; Hisashi Tanaka; Hitoshi Terada; Noriyuki Tomiyama
Journal:  Jpn J Radiol       Date:  2021-06-14       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.